Kingsview Wealth Management LLC grew its holdings in Marsh & McLennan Companies, Inc. (NYSE:MMC – Get Rating) by 9.8% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 5,846 shares of the financial services provider’s stock after acquiring an additional 522 shares during the period. Kingsview Wealth Management LLC’s holdings in Marsh & McLennan Companies were worth $873,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the business. Penserra Capital Management LLC lifted its holdings in Marsh & McLennan Companies by 2.6% in the 3rd quarter. Penserra Capital Management LLC now owns 2,413 shares of the financial services provider’s stock worth $360,000 after buying an additional 62 shares during the period. Miracle Mile Advisors LLC lifted its stake in shares of Marsh & McLennan Companies by 0.5% in the 3rd quarter. Miracle Mile Advisors LLC now owns 13,380 shares of the financial services provider’s stock valued at $1,997,000 after purchasing an additional 64 shares during the period. Global Retirement Partners LLC lifted its stake in shares of Marsh & McLennan Companies by 1.7% in the 3rd quarter. Global Retirement Partners LLC now owns 3,938 shares of the financial services provider’s stock valued at $636,000 after purchasing an additional 65 shares during the period. Donaldson Capital Management LLC increased its holdings in shares of Marsh & McLennan Companies by 1.4% in the 2nd quarter. Donaldson Capital Management LLC now owns 4,637 shares of the financial services provider’s stock worth $720,000 after purchasing an additional 66 shares in the last quarter. Finally, Axxcess Wealth Management LLC increased its holdings in shares of Marsh & McLennan Companies by 4.7% in the 2nd quarter. Axxcess Wealth Management LLC now owns 1,503 shares of the financial services provider’s stock worth $233,000 after purchasing an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 87.30% of the company’s stock.
Marsh & McLennan Companies Price Performance
NYSE MMC opened at $157.26 on Wednesday. The company has a market capitalization of $77.78 billion, a PE ratio of 26.12, a price-to-earnings-growth ratio of 2.48 and a beta of 0.93. The company has a debt-to-equity ratio of 1.04, a quick ratio of 1.16 and a current ratio of 1.16. The business’s fifty day moving average is $168.37 and its 200 day moving average is $164.35. Marsh & McLennan Companies, Inc. has a fifty-two week low of $143.33 and a fifty-two week high of $183.14.
Marsh & McLennan Companies Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 15th. Stockholders of record on Thursday, January 26th were given a $0.59 dividend. The ex-dividend date of this dividend was Wednesday, January 25th. This represents a $2.36 annualized dividend and a dividend yield of 1.50%. Marsh & McLennan Companies’s payout ratio is 39.20%.
Analyst Ratings Changes
A number of analysts have commented on the company. Wells Fargo & Company lifted their target price on Marsh & McLennan Companies from $190.00 to $197.00 and gave the stock an “overweight” rating in a report on Friday, January 27th. Royal Bank of Canada lifted their target price on Marsh & McLennan Companies from $170.00 to $180.00 and gave the stock a “sector perform” rating in a report on Friday, January 27th. Jefferies Financial Group lowered Marsh & McLennan Companies from a “buy” rating to a “hold” rating and reduced their target price for the stock from $181.00 to $178.00 in a report on Monday, January 9th. They noted that the move was a valuation call. Citigroup lifted their price objective on Marsh & McLennan Companies from $185.00 to $190.00 and gave the stock a “neutral” rating in a report on Wednesday, February 1st. Finally, Raymond James lifted their price objective on Marsh & McLennan Companies from $180.00 to $185.00 and gave the stock an “outperform” rating in a report on Monday, January 30th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Marsh & McLennan Companies has an average rating of “Hold” and an average price target of $178.62.
Insider Activity
In other news, CEO Dean Michael Klisura sold 3,140 shares of the business’s stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $165.22, for a total value of $518,790.80. Following the transaction, the chief executive officer now directly owns 20,935 shares in the company, valued at $3,458,880.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Oscar Fanjul sold 2,900 shares of the business’s stock in a transaction dated Wednesday, February 8th. The stock was sold at an average price of $173.70, for a total value of $503,730.00. Following the sale, the director now directly owns 75,447 shares in the company, valued at $13,105,143.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Dean Michael Klisura sold 3,140 shares of the business’s stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $165.22, for a total value of $518,790.80. Following the completion of the sale, the chief executive officer now owns 20,935 shares in the company, valued at $3,458,880.70. The disclosure for this sale can be found here. Company insiders own 0.81% of the company’s stock.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Recommended Stories
- Get a free copy of the StockNews.com research report on Marsh & McLennan Companies (MMC)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts DefendĀ
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC – Get Rating).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.